ENTITY
Imugene Ltd

Imugene Ltd (IMU AU)

68
Analysis
Health Care • Australia
Imugene Limited is a health biotechnology development company. The Company manufactures vaccines for gastric and breast cancer treatments. Imugene operates in Europe and Australia.
more
bullish•Data#3 Ltd
•19 Jul 2023 05:09

S&P/ASX200 Ad Hoc Index Rebalance & Update to Potential Changes in September

Ventia replaces Blackmores in the ASX200 at the close on 21 July. That also leads to changes to potential adds/deletes in September. WBT and DTL...

Logo
731 Views
Share
•16 Jul 2023 05:30

Index Rebalance & ETF Flow Recap: ASX, Chinext, URA, Korea Stocks, NKY

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
726 Views
Share
bullish•Quantitative Analysis
•03 Apr 2023 05:47

Short Interest Movements (Q1 2023): HK, Korea, Taiwan, Australia

The Insight looks at movements in short interest across HK, Korea, Taiwan and Australia stocks over Q1 and highlights large increases/decreases in...

Logo
536 Views
Share
bearish•Quantitative Analysis
•31 Mar 2023 06:00

ASX Short Interest Weekly (Mar 24th): Pilbara Minerals, Aurizon, Arafura Rare Ear, New Hope

We analyzed ASX short interest report for the past week and highlight short interest changes in Pilbara Minerals, Aurizon, Arafura Rare Ear, New...

Logo
532 Views
Share
bearish•Quantitative Analysis
•23 Mar 2023 16:20

ASX Short Interest Weekly (Mar 17th): Pilbara Minerals, Northern Star Re, Arafura Rare Ear, Aurizon

We analyzed ASX short interest report for the past week and highlight short interest changes in Pilbara Minerals, Northern Star Re, Arafura Rare...

Logo
493 Views
Share
x